Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36899 |
INCB086550
PD-1/PD-L1-IN-8 |
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
INCB086550 (PD-1/PD-L1-IN-8) (example 24) 是 PD-1/PD-L1 的抑制剂,其IC50 值为 <= 10 nM。 | |||
T61968 | PD-1/PD-L1-IN 6 | ||
PD-1/PD-L1-IN 6 (compound A13) 是有效的PD-1/PD-L1相互作用抑制剂(IC50为 132.8 nM)。PD-1/PD-L1-IN 6 显示出显著的免疫调节活性。 在 Hep3B/OS-8/hPD-L1 与 CD3 T 细胞共培养模型中,PD-1/PD-L1-IN 6显著提高干扰素 -γ 分泌,且无明显毒性作用。 在 T 细胞-肿瘤共培养模型中,PD-1/PD-L1-IN 6恢复免疫应答。 | |||
T40112 |
PROTAC PD-1/PD-L1 degrader-1
PROTAC PD-1/PD-L1 degrader-1 |
||
PROTAC PD-1/PD-L1 degrader-1, a Cereblon E3 ligand-based compound, is a PD-1/PD-L1 PROTAC that effectively inhibits the interaction between PD-1 and PD-L1 with an IC50 value of 39.2 nM. It successfully restores the suppressed immune response in a co-culture model consisting of Hep3B/OS-8/hPD-L1 cells and CD3 T cells. Additionally, this compound moderately decreases PD-L1 protein levels through a lysosome-dependent mechanism. | |||
T74348 | HE-S2 | PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
HE-S2是一种具有显著抗肿瘤活性的抗体偶联活性分子,它通过阻断PD-1/PD-L1相互作用并激活Toll样受体7/8 (TLR7/8)信号通路,触发有效的抗肿瘤免疫反应。 | |||
T79069 | TLR7/8 agonist 9 | ||
TLR7/8 agonist 9 (Compound 25a) 是一种能够增强PD-1/PD-L1阻断疗法抗肿瘤效果的化合物,主要用于癌症免疫疗法研究。它对hTLR7和hTLR8的EC50分别为40 nM和23 nM,显示出其对这两种受体的高亲和力以及潜在的抗肿瘤活性。 | |||
T79068 | TLR7/8 agonist 8 | ||
TLR7/8 agonist 8(compound 24m)是一种高效的TLR7/8双重激动剂,对hTLR7和hTLR8的EC50值分别为27 nM和12 nM。该化合物能增强PD-1/PD-L1阻断剂的抗癌效果。 |